Diagnostics Announces Intention To Submit Enhanced Version Of Covid-19 Test To FDA
21/02/2025 22:47
Feb 21 (Reuters) - Co-Diagnostics Inc CODX.O :
* CO-DIAGNOSTICS, INC. ANNOUNCES INTENTION TO SUBMIT
ENHANCED
VERSION OF COVID-19 TEST TO FDA FOR 510(K) CLEARANCE
* CO-DIAGNOSTICS INC - WITHDRAWS 510(K) APPLICATION FOR
COVID-19
TEST
Source text: ID:nPn6rl0yRa
Further company coverage: CODX.O
Recent news on Co-Diagnostics
See all newsDiagnostics' Joint Venture Cosara Diagnostics Announces Publication Of Peer-Reviewed Hpv Screening Study Using Cosara's Saragene® Test
Diagnostics - Cosara To Initiate Sales Activities Across India And South Asia
Diagnostics’ Brian Brown Stepped Down As CFO Effective September 2
Diagnostics Q2 revenue rises slightly amid international expansion
Diagnostics - Amends Equity Distribution Agreement With Maxim Group For Common Stock Sale - SEC Filing